Advancing Pipeline

We are advancing our clinical pipeline of first-in-class monoclonal antibodies with broad-spectrum potential in cancer and viral infections.
|
 |
Clinical Trials

We have multiple company-sponsored clinical trials and an investigator-sponsored trials (IST) program.
|
 |
Biomanufacturing Subsidiary

Our subsidiary Avid Bioservices provides a comprehensive range of biomanufacturing services for its clients and manufactures clinical products for our trials.
|
 |
Government Contract

Our government contract with the TMTI covers research for up to a five-year period, potentially worth up to $44.5M.
|
 |
2010 Annual Report

Leading the clinical development of a new class of targeted therapeutics.
|